Overview

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety of pregabalin in refractory partial epilepsy.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin